Fig. 1
From: Phase I dose-escalation oncology trials with sequential multiple schedules
Scenarios 7-13 in the simulation study. Each scenario includes two curves of dose and DLT probabilities, which represents two schedules. Two schedules are the frequency of administration of 48 (S1) and 24 hours (S2). The horizontal dashed lines represent the boundaries of the targeted toxicity interval